Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)

The purpose of that register is to collect medical information about patients suffering of APS with or without associated SLE.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anti-Phospholipids Syndrome (APS) Antiphospholipid Syndrome Autoimmune Diseases Connective Tissue Diseases Immune System Diseases Lupus Erythematosus, Systemic Skin and Connective Tissue Diseases Systemic Lupus Erythematosus (SLE)

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Cochin, Paris, PARIS, France

About this study

Recruitment of patients with APS and SLE treated. Retrospective and prospective register.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient with APS
Patient with SLE

Exclusion criteria

Dependent person
Hospitalized without consent and not protected by law
Detainee

Treatment and study plan

Primary outcomes

Number of patients enrolled with Anti-Phospholipids syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)

Time frame: 5 years

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Collaborators

URC-CIC Paris Descartes Necker Cochin

Registry information

Acronym: SAPL-LUPUS

Important dates

Study start: 2017
Primary completion: 2022
Study completion: 2022
First posted: May 25, 2016
Registry last updated: Nov 20, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting